ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 337

$484K Total Retail Price of All Prescriptions

Rank: 81 out of 337

339 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,110 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 574 492 1 3
SIMVASTATIN 553 465 2 1
LISINOPRIL 407 391 3 2
FUROSEMIDE 358 320 4 8
LEVOTHYROXINE SODIUM 289 255 5 5
ATORVASTATIN CALCIUM 270 246 6 7
OMEPRAZOLE 249 197 7 4
ATENOLOL 234 210 8 10
METOPROLOL TARTRATE 233 212 9 6
HYDROCODONE-ACETAMINOPHEN 228 142 S3 10 13
METOPROLOL SUCCINATE 214 214 11 21
HYDROCHLOROTHIAZIDE 180 172 12 9
PRAVASTATIN SODIUM 171 150 13 14
ZOLPIDEM TARTRATE 170 127 14 23
POTASSIUM CHLORIDE 154 116 15 62
METFORMIN HCL 153 153 16 12
WARFARIN SODIUM 135 115 17 11
TRIAMTERENE-HCTZ 134 126 18 39
CITALOPRAM HBR 127 114 19 17
TRAZODONE HCL 125 100 20 16
OXYCODONE-ACETAMINOPHEN 118 34 S2 21 84
DIOVAN 111 79 22 26
DILTIAZEM 24HR ER 111 108 22 76
NEXIUM 107 83 24 56
SYNTHROID 104 104 25 41
ACETAMINOPHEN-CODEINE 100 91 S3 26 142
ALLOPURINOL 97 95 27 28
LOSARTAN POTASSIUM 93 92 28 15
GLIPIZIDE ER 89 84 29 69
CLONIDINE HCL 83 72 30 135
TRAMADOL HCL 80 40 31 32
PREDNISONE 78 60 32 40
ADVAIR DISKUS 76 67 33 44
GABAPENTIN 76 45 33 20
SERTRALINE HCL 75 75 35 18
TAMSULOSIN HCL 73 73 36 25
FLUOXETINE HCL 73 24 36 57
CRESTOR 72 58 38 29
DONEPEZIL HCL 68 68 39 22
JANUVIA 68 58 39 81
GLIPIZIDE XL 68 62 39 123
DIGOXIN 67 67 42 58
CYCLOBENZAPRINE HCL 61 30 R 43 103
PROAIR HFA 61 43 43 38
DIOVAN HCT 59 59 45 88
GLYBURIDE 59 59 R 45 53
CLOPIDOGREL 56 56 47 42
FLUTICASONE PROPIONATE 56 40 47 34
MIRTAZAPINE 55 54 49 27
VERAPAMIL ER 54 51 50 77
GLIPIZIDE 50 50 51 45
NITROFURANTOIN 50 50 51 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.